From the Editor-in-Chief

Publisher： Elsevier

ISSN： 0306-3623

Source： General Pharmacology, Vol.34, Iss.1, 2000-01, pp. : 1-2

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Letter from the Editor-in-Chief

By MOY RONALD L.

Dermatologic Surgery, Vol. 23, Iss. 1, 1997-01 ,pp. : 11-12

Elsevier

Access to resources Recommend Favorite

Editorial from Editor-in-Chief

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 10, Iss. 4, 2011-08 ,pp. : 226-226

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial from Editor-in-Chief

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 9, Iss. 1, 2010-03 ,pp. : 1-1

Bentham Science Publishers

Access to resources Recommend Favorite

Message from the Editor-in-Chief:

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 15, Iss. 1, 2016-02 ,pp. : 2-2

Bentham Science Publishers

Access to resources Recommend Favorite

Message from Editor-in-Chief

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 13, Iss. 1, 2014-02 ,pp. : 1-1

Bentham Science Publishers

Access to resources Recommend Favorite